Tanshinone IIA, a bioactive phytochemical from Salvia miltiorrhiza Bunge, attenuates lipid accumulation by modulating the LXRα–SREBP1 pathway to treat MASLD [118]. Here, NR1H3 is linked to metabolic dysfunction-associated steatotic liver disease.